Octave Specialty Group

AMBC · NYSE

$4.75+$0.13 (+2.81%)TodayMarket closed ·
Prev close $4.62

Key indicators

AMBC profitability and balance sheet ratios

EPS -$2.34 in Sep 2025, against -$0.5871 a year earlier.

EPS by quarter
PeriodEPS
Dec 2023-$0.351
Mar 2024$0.4315
Jun 2024$0.00
Sep 2024-$0.5871
Dec 2024-$11.39
Mar 2025-$0.9805
Jun 2025-$1.51
Sep 2025-$2.34

Income statement

No financial statements are reported for Octave Specialty Group.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.